WEST PALM BEACH, FL — (Marketwire) — 07/25/11 — (OTCQB: TCLN) (PINKSHEETS: TCLN) today announced that it has signed a Definitive Merger Agreement with Quture Inc. (“Quture”). In the merger, TCLN seeks to acquire a hundred percent interest in Quture to significantly increase shareholder value. The assets of Quture include extensive intellectual property, enhanced software products on the leading technology platform, and clinical content from over 35 years as a leading clinical performance company in the United States. Upon closing, Quture will have accessibility to the capital markets for its financing needs and have currency to achieve dominance as the international standard to measure clinical performance in healthcare consistent with its aggressive growth strategy. Quture seeks to become transparent through public reporting and subject to the requirements for public companies are consistent with that corporate strategy. Closing is subject to customary exchange and approval of schedules and exhibits, audited financial statements, and completing due diligence.
“The acquisition of Quture is an exciting opportunity for the Company and is part of our strategy to increase shareholder value. The implementation of public reporting and policies linking payment to healthcare outcomes has significant implications for the future of healthcare. Our Country faces the challenge of improving healthcare with the understanding that continued growth in healthcare costs is not economically sustainable. Quture-s development of a quality performance measurement system positions the Company to transform healthcare by developing the national standard in measuring clinical performance,” stated Henry Fong, CEO of Techs Loanstar.
Landon Feazell, Chairman & CEO of Quture, stated: “Merging to become publicly traded and fully reporting is a key corporate strategy. We are committed to the company becoming a dominant player in the private enterprise solutions to improve care and reduce costs of health and healthcare. This merger will strengthen Quture financially while also providing transparency and accountability to the public and to our shareholders. We believe our business proposition and revenue model are sound and that the future of Quture in healthcare performance, outcomes, value, and optimal quality and patient safety are without parallel.”
About Quture
Quture, Inc., is a Nevada corporation operating from corporate offices primarily in Florida. Quture-s mission is to become the Gold Standard in Healthcare Performance Measurement. Quture provides healthcare organizations, insurers, government payers, and other stakeholders in the healthcare community with performance measurement tools and data sets. Industry experts agree that these performance measures are the “transformative tool” that reduce medical cost and improve quality of care. Quture-s management team has 35 years of experience and a long history of working with many of the nation-s leading healthcare institutions and insurers as a leader and innovator in measuring clinical performance. Quture plans include developing a revolutionary solution to effectively and efficiently measure clinical performance from multiple vendor databases.
About Techs Loanstar, Inc.
Techs Loanstar, Inc., a Nevada company, was initially organized to provide loan management service and software for the equity and payday loan industry. Upon completion of a Share Exchange Agreement in February 2010, Techs ceased all operations relating to its historical business and adopted the business plan of ZenZuu USA, Inc. (“ZZUSA”). ZZUSA was formed to acquire an exclusive license to use and operate in the United States, an online social database and advertising revenue-share model for the purpose of seeking a business opportunity in the online social network industry.
Forward-Looking Statements
This release contains forward-looking statements, including, without limitation, statements concerning our business and possible or assumed future results of operations. Our actual results could differ materially from those anticipated in the forward-looking statements for many reasons including: our ability to continue as a going concern, adverse economic changes affecting markets we serve; competition in our markets and industry segments; our timing and the profitability of entering new markets; greater than expected costs, customer acceptance of our products or difficulties related to our integration of the businesses we may acquire; and other risks and uncertainties as may be detailed from time to time in our public announcements and SEC filings. Although we believe the expectations reflected in the forward-looking statements are reasonable, they relate only to events as of the date on which the statements are made, and our future results, levels of activity, performance or achievements may not meet these expectations. We do not intend to update any of the forward-looking statements after the date of this document to conform these statements to actual results or to changes in our expectations, except as required by law. There is no assurance that the finalization of the definitive agreement will be completed.
For Further Information Contact:
Constellation Asset Advisors, Inc.
Jens Dalsgaard
President
+1 (415) 524-8500
You must be logged in to post a comment Login